Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

NCT06429449 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myeloid Leukemia
Monocytic Leukemia

Interventions

DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Mitoxantrone

Sponsor

University of Colorado, Denver

Collaborators

[object Object]